Barclays Maintains an 'Overweight' on Jones Lang LaSalle (JLL); Highlights From Mgmt Meeting
Get Alerts JLL Hot Sheet
Price: $375.00 +1.48%
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays maintains an 'Overweight' on Jones Lang LaSalle (NYSE: JLL) price target of $95.00.
Analyst, Ross L. Smotrich, said, "Management's tone was positive, underscored by the belief that the commercial real estate recovery is in its middle innings. In that vein, management expects an upward trend in its overall business over the next few years, albeit with a fair amount of volatility."
Smotrich thinks the instability in Europe is a negative, however, he sees some degree of letting up and notes the company's balance sheet and growth in share.
For an analyst ratings summary and ratings history on Jones Lang LaSalle click here. For more ratings news on Jones Lang LaSalle click here.
Shares of Jones Lang LaSalle closed at $69.87 yesterday.
Analyst, Ross L. Smotrich, said, "Management's tone was positive, underscored by the belief that the commercial real estate recovery is in its middle innings. In that vein, management expects an upward trend in its overall business over the next few years, albeit with a fair amount of volatility."
Smotrich thinks the instability in Europe is a negative, however, he sees some degree of letting up and notes the company's balance sheet and growth in share.
For an analyst ratings summary and ratings history on Jones Lang LaSalle click here. For more ratings news on Jones Lang LaSalle click here.
Shares of Jones Lang LaSalle closed at $69.87 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
- Freedom Broker Upgrades Lifeway Foods (LWAY) to Buy
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share